This Center focuses on developing new treatments for rare, ultra-rare and rare variants of common diseases.
Harrington Discovery Institute and The University of Oxford have formed a unique partnership combining world-leading strengths in research and therapeutics development. The Oxford-Harrington Centre will advance knowledge into cures for rare diseases across the United Kingdom and the United States.
Advancing Novel Treatments for Rare Neurological Diseases
Harrington Discovery Institute Brings Families Hope
Haiyan Zhou, MD, PhD, Hereditary Nerve Damage Disorder Therapy
Professor Matthew Wood
Director, Oxford-Harrington Rare Disease Centre; Professor of Neuroscience, University of Oxford
Chief Scientific Officer, Harrington Discovery Institute, Chief Academic Officer, University Hospitals Health System; Chief Research Officer, University Hospitals Harrington Heart and Vascular Institute; the Ellery Sedgwick Jr. Chair and Distinguished Scientist, Vice Dean for Academic Affairs, and Vice Dean for Medical Sciences, and Professor of Medicine, Case Western Reserve University School of Medicine
Sir John Bell
Regius Professor of Medicine, University of Oxford
Georg Holländer, MD
Head of Department of Paediatrics, University of Oxford
Jonathan Stamler, MD
President, Harrington Discovery Institute
Supports UK researchers in the development of cures and therapies for rare disease.
